Literature DB >> 29804777

Evaluation of sexual function in women with deep infiltrating endometriosis.

Mauro Cozzolino1, Elena Rita Magro-Malosso2, Lorenzo Tofani3, Maria Elisabetta Coccia2.   

Abstract

INTRODUCTION: The influence of deep infiltrating endometriosis (DIE) on sexual function has been poorly studied. The aim of this study was to evaluate the impact of DIE on sexual function by administering questionnaires to women.
METHODS: Women with a clinical and ultrasound diagnosis of DIE and histological confirmation of endometriosis were included in the study. In interview, women were asked to rate five pain symptoms, dysmenorrhea, dyspareunia, dyschezia, dysuria and Cronic Pelvic Pain (CPP), on a visual analogue scale (VAS), and sexual function was assessed using the Female Sexual Function Index (FSFI).
RESULTS: A total of 170 women with DIE were identified. A VAS score of 7 or more was taken to indicate that a symptom was 'severe'. Dysmenorrhea was reported to be severe by 66.5% of the sample, dyspareunia by 41.8%, dyschezia by 32.4% and dysuria by 6.5%. Mean FSFI scores did not differ significantly between women with and without endometriosis lesions at particular sites, except for rectovaginal nodules, which were found to be associated with more impaired sexual activity and sexual function.
CONCLUSIONS: Women with DIE had significant impairment of sexual activity when a partial or total infiltration of the rectovaginal septum occurred. Particular attention should be given to women with this kind of lesion.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Deep infiltrating endometriosis (DIE); Female Sexual Function Index (FSFI); Sexual activity; Sexual function; Visual analogue scale (VAS)

Mesh:

Year:  2018        PMID: 29804777     DOI: 10.1016/j.srhc.2017.12.005

Source DB:  PubMed          Journal:  Sex Reprod Healthc        ISSN: 1877-5756


  7 in total

1.  Partners matter: The psychosocial well-being of couples when dealing with endometriosis.

Authors:  Maren Schick; Ariane Germeyer; Bettina Böttcher; Stephanie Hecht; Magdalena Geiser; Sabine Rösner; Monika Eckstein; Kilian Vomstein; Bettina Toth; Thomas Strowitzki; Tewes Wischmann; Beate Ditzen
Journal:  Health Qual Life Outcomes       Date:  2022-05-28       Impact factor: 3.077

Review 2.  A systematic review on the effects of endometriosis on sexuality and couple's relationship.

Authors:  P Norinho; M M Martins; H Ferreira
Journal:  Facts Views Vis Obgyn       Date:  2020-10-08

Review 3.  A comparison of sacral neuromodulation vs. transvaginal electrical stimulation for the treatment of refractory overactive bladder: the impact on quality of life, body image, sexual function, and emotional well-being.

Authors:  Valentina Lucia La Rosa; Alessio Platania; Michał Ciebiera; Simone Garzon; Robert Jędra; Marco Ponta; Salvatore Butticè
Journal:  Prz Menopauzalny       Date:  2019-06-28

4.  Endometriosis and Sexual Quality of Life.

Authors:  Mikal van Poll; Esther van Barneveld; Luca Aerts; Jacques W M Maas; Arianne C Lim; Bianca T A de Greef; Marlies Y Bongers; Nehalennia van Hanegem
Journal:  Sex Med       Date:  2020-07-22       Impact factor: 2.491

Review 5.  Impact of Endometriosis on Life-Course Potential: A Narrative Review.

Authors:  Stacey A Missmer; Frank F Tu; Sanjay K Agarwal; Charles Chapron; Ahmed M Soliman; Stephanie Chiuve; Samantha Eichner; Idhaliz Flores-Caldera; Andrew W Horne; Alexandra B Kimball; Marc R Laufer; Nicholas Leyland; Sukhbir S Singh; Hugh S Taylor; Sawsan As-Sanie
Journal:  Int J Gen Med       Date:  2021-01-07

6.  Constellations of pain: a qualitative study of the complexity of women's endometriosis-related pain.

Authors:  Sarah J Drabble; Jaqui Long; Blessing Alele; Alicia O'Cathain
Journal:  Br J Pain       Date:  2020-10-07

7.  Interference and Impact of Dysmenorrhea on the Life of Spanish Nursing Students.

Authors:  Ana Abreu-Sánchez; Javier Ruiz-Castillo; María Dolores Onieva-Zafra; María Laura Parra-Fernández; Elia Fernández-Martínez
Journal:  Int J Environ Res Public Health       Date:  2020-09-05       Impact factor: 3.390

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.